|
|
Abstract Submission The International Narcotics Research Conference
2010
Malmö, Sweden
Dates: July 11 (Sun) to July 16 (Fri),
2010
Abstract submission deadline is
April 1, 2010
As many active participants as
possible are welcome at INRC meetings. Abstracts should be provided
for poster presentations, as well as all oral presentations
including Symposia, Founder, and Plenary lectures. If you haven't
been invited to give an oral presentation, please plan on preparing
a poster. Some authors will be invited to give a short oral
presentation after submission of an abstract.
Posters: To accommodate all
posters on display for the duration of the meeting, poster boards
are 4' by 8' but will be shared by two posters. Thus the maximum
size for each poster presentation is 4 feet by 4 feet (height and width of 48 inches (120cm)
each). However as space is needed between the two posters sharing a
side, please use:
poster size: 44 inches high by
44 inches wide (110 cm by 110 cm)
Pushpins to mount the posters will
be provided.
You will find
your abstract number in the abstract book which you will obtain when
registering for the meeting in Portland or earlier on the INRC
website.
Abstract Submission
Instructions
Abstracts may only be submitted
electronically for this meeting. Please note the abstract submission
deadline of April 1, 2010!
Please type up your abstract
according to this sample:
INVOLVEMENT OF GLT-1, A GLIAL GLUTAMATE
TRANSPORTER, IN PHYSICAL AND PSYCHOLOGICAL MORPHINE DEPENDENCE
T. Nakagawa (1), T. Ozawa (1), Y. Sekiya (1), H. Ueda (2), M.
Satoh (1) (1)Dept. of Mol. Pharmacol., Grad. Sch. of Pharmaceut.
Sci., Kyoto Univ., Kyoto, Japan, (2)Dept. of Mol. Pharmacol. and
Neurosci., Sch. of Pharmaceut. Sci.,Nagasaki Univ., Nagasaki,
Japan
We previously reported the changes in the
expression of the glial glutamate transporter GLT-1 mRNA in some
brain regions of morphine-dependent rats. In this study, we
examined the roles of GLT-1 in physical and psychological
dependence on morphine......blah, blah, blah, blah, blah, blah,
blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah,
blah, blah, blah, blah, blah,blah, blah, blah, blah, blah,
blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah,
blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah,
blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah,
blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,...etc,
etc ........................................... DON'T FORGET to acknowledge
your funding source at end!!
Do NOT use Greek
symbols but spell out symbols as much as possible. Use character
count tools! Keep total characters (including titles, names,
institutions & spaces) to no more than 1400 characters.
Please indicate a maximum of 2
keywords in your email. The following symposia are planned and
additional short oral presentations will be chosen from submitted
abstracts.
1. Novel opioid peptide agonists
and antagonists
2. Transcription and epigenetics of opioid peptide genes
3. Ligand-directed Signaling and Functional Selectivity
4. Opioids in neuropathic pain - Preclinical part
5. Opioids in neuropathic pain - Clinical part
6. Opioids & stem cell research - Recent progress in the stem cell
biology and adult neurogenesis
7. Opioids, Incentive Drive and Habit
8. Opioid addiction – Clinical aspects
9. Opioids in alcohol addiction - Preclinical research
10. Opioids in addiction to alcohol and central stimulants -
Clinical research
11. Endogenous opioids and addiction to gambling
12. Opioids in neuroendocrinology – abuse of steroids
13. Opioid and cannabinoid interaction (joint session with the ICRS)
If your email program does not allow attachments, please paste text
of your abstract directly in the body of an email.
File type: Word.doc is preferred.
Font: Times or Times New Roman.
Size: No more than 1400 characters including titles, authors,
and spaces.
Please indicate in the body of your email if you are willing to present an
oral
presentation if selected.
Symposia, Founder, and Plenary lecturers abstracts can be
2800 characters at most.
IMPORTANT! Please name your abstract word file with your last
name,
then initials of your other names.
(for example "stevenscw.doc" for "Craig W. Stevens")
Save your abstract document as a Microsoft word doc, attach it to an
email with the subject
line as "INRC Abstract", and send to Dr. Fred Nyberg at:
inrc.malmo.2010@gmail.com
Abstract Publication
Abstracts will be available for viewing at the INRC website and in
the abstract book distributed at the Meeting.
As further information becomes
available, announcements will be made to the INRC-L email list. If you are
not already on the INRC-list server, please send your current e-mail
address, full name and institutional affiliation to:
Craig W. Stevens, Ph.D.
INRC Information Officer
at:
cw.stevens@okstate.edu
|
Comments or suggestions can be emailed to
the INRC Information Officer at: cw.stevens@okstate.edu
This site supported by server space and
system administration generously
donated by OSU-Center
for Health Sciences, Tulsa, OK, U.S.A. |